Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
96M
-
Number of holders
-
98
-
Total 13F shares, excl. options
-
26.4M
-
Shares change
-
+6.32M
-
Total reported value, excl. options
-
$1.5B
-
Value change
-
+$358M
-
Put/Call ratio
-
0.24
-
Number of buys
-
71
-
Number of sells
-
-26
-
Price
-
$56.60
Significant Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q3 2014
110 filings reported holding RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK as of Q3 2014.
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.4M shares
of 96M outstanding shares and own 27.56% of the company stock.
Largest 10 shareholders include FMR LLC (4.59M shares), Capital Research Global Investors (3.83M shares), TPG Group Holdings (SBS) Advisors, Inc. (2.6M shares), COLUMBIA WANGER ASSET MANAGEMENT LLC (1.79M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.32M shares), VANGUARD GROUP INC (1.09M shares), WELLINGTON MANAGEMENT CO LLP (1.08M shares), ADAGE CAPITAL PARTNERS GP LLC (1.05M shares), FIL Ltd (1.03M shares), and JENNISON ASSOCIATES LLC (759K shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.